The approval of COVID-19 vaccines was the breakthrough for mRNA-based technology, and it opened so many opportunities for mRNA-based vaccines and therapeutics. CHI’s 2nd Annual mRNA-Based Therapies conference will explore the technical challenges facing the manufacture and purification, formulation, development, scale-up, and supply of next-generat
16-17 August 2023